PepGuide

Glycoprotein hormone (FDA-approved for specific fertility and hypogonadism indications)

Human chorionic gonadotropin

A gonadotropin hormone approved for fertility and select hypogonadism protocols; stimulates testosterone and spermatogenesis.

Evidence:
Strong human evidence
Status:
FDA-approved for specific labeled indications
Reviewed:
2026-08-03

Also known as: Human chorionic gonadotropin, Pregnyl, Novarel

What is Human chorionic gonadotropin?

A gonadotropin hormone approved for fertility and select hypogonadism protocols; stimulates testosterone and spermatogenesis.

This profile is educational. It organizes publicly discussed research context for Human chorionic gonadotropin and related naming aliases — it is not a treatment guide.

Proposed mechanism

Activates LH/CG receptors on Leydig cells (testosterone) and supports FSH-mediated spermatogenesis in combination protocols.

Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.

Current research notes

Human evidence grade: Strong human evidence

Preclinical evidence grade: Strong human evidence

HCG is FDA-approved for cryptorchidism, hypogonadotropic hypogonadism, and fertility protocols. Used in male hypogonadism to preserve testicular function alongside TRT in some protocols. Human evidence is strong within approved uses. Misuse for weight loss (HCG diet) is not supported by evidence.

Key uncertainties

  • Optimal protocols for male fertility preservation on TRT

Research areas being studied

  • Male hypogonadism
  • Fertility
  • Cryptorchidism

Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.

Safety & side-effect notes

Reported or discussed adverse effects

  • Injection-site pain
  • Headache
  • Mood changes
  • Acne

Additional risks & considerations

  • Gynecomastia
  • Erythrocytosis with testosterone rise
  • Ovarian hyperstimulation in women

Regulatory status

FDA-approved for specific labeled indications

FDA approved for specific fertility and hypogonadism indications.

Regulatory framing here is educational and can lag policy changes. Check official sources for current status.

Frequently asked questions

What is Human chorionic gonadotropin?

A gonadotropin hormone approved for fertility and select hypogonadism protocols; stimulates testosterone and spermatogenesis.

How does Human chorionic gonadotropin work (proposed mechanism)?

Activates LH/CG receptors on Leydig cells (testosterone) and supports FSH-mediated spermatogenesis in combination protocols.

What is Human chorionic gonadotropin being researched for?

Human chorionic gonadotropin has been discussed in research contexts including: Male hypogonadism, Fertility, Cryptorchidism.

What does current evidence say about Human chorionic gonadotropin?

Strong human evidence. HCG is FDA-approved for cryptorchidism, hypogonadotropic hypogonadism, and fertility protocols. Used in male hypogonadism to preserve testicular function alongside TRT in some protocols. Human evidence is strong within approved uses. Misuse for weight loss (HCG diet) is not supported by evidence.

What safety considerations are noted for Human chorionic gonadotropin?

Reported or discussed considerations include: Injection-site pain; Headache; Mood changes; Acne; Gynecomastia; Erythrocytosis with testosterone rise; Ovarian hyperstimulation in women. This is educational information, not medical advice.

Is Human chorionic gonadotropin FDA approved?

FDA-approved for specific labeled indications. FDA approved for specific fertility and hypogonadism indications.

References & sources

  • Wenker EP et al. (2015). HCG in male hypogonadism and fertility preservation — Asian J Androl. Evidence type: review.

Prefer interactive tools? Open the PepGuide library entry for Human chorionic gonadotropin or ask PepGuide AI.

Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.